Send E-mail
  • Yuhan inks deal with China’s Luoxin Biotech
    Yuhan inks deal with China’s Luoxin Biotech
    Yuhan Corp. (000100) announced on July 28 that it has signed a technology transfer deal with China’s Luoxin Biotechonology for YH25448, a new targeted therapy for lung cancer.The firm will receive an upfront payment of US$6 million and subsequent milestone payments that amount up to US$120 million.
From
Send to
Close Send

Yuhan inks deal with China’s Luoxin Biotech

July 28, 2016 - 10:49 By 정민경
[DISCLOSURE] Yuhan Corp. (000100) announced on July 28 that it has signed a technology transfer deal with China’s Luoxin Biotechonology for YH25448, a new targeted therapy for lung cancer.

The firm will receive an upfront payment of US$6 million and subsequent milestone payments that amount up to US$120 million.
Most Popular